RxDoctor Payments Data

Trina Ryan

Family · Milan, TNNPI 1265859433

Payments from drug & device makers

$968in general payments, 2019–2025

Across 63 payments — averaging $15.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$231
  • Biohaven Pharmaceutical Holding Company Ltd.$181
  • Lilly USA, LLC$149
  • Biohaven Pharmaceuticals, Inc.$101
  • Pfizer$91
  • Bayer$63
  • plus $152 from 6 others

What the payments were for

  • Food & beverage$968100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$968 in reported general payments places this provider in the 60th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$64,868
Medicare patients
150
Services billed
2,845

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide54$91,801
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$34,164
EliquisApixaban30$29,099
VraylarCariprazine Hcl13$18,489
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog12$12,846
Tizanidine Hcl62$2,035
Gabapentin168$2,032
Duloxetine Hcl61$1,515
Omeprazole94$1,489
Atorvastatin Calcium106$1,218
Ezetimibe25$964
Famotidine41$897
Pravastatin Sodium56$826
Losartan Potassium101$804
Pantoprazole Sodium56$792

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$19$91,80154 claims
PfizerEliquis$91$29,09930 claims
AbbVieVraylar$231$18,48913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,706 family providers in Tennessee.

Other family in Milan

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →